Telix Pharmaceuticals Limited ADR (TLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TLX | AZN | AMGN | GILD | BMY |
| Company | Telix Pharmaceuticals Limited ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 10.40 | 197.04 | 345.03 | 133.84 | 59.63 |
| High | 10.40 | 197.04 | 345.03 | 133.84 | 59.63 |
| Low | 10.40 | 197.04 | 345.03 | 133.84 | 59.63 |
| Latest | 10.40 | 197.04 | 345.03 | 133.84 | 59.63 |
| Change | +0.17 | +1.26 | +0.17 | +0.55 | +0.24 |
| % Change | +1.65% | +0.64% | +0.05% | +0.41% | +0.40% |
| Volume | 6,886 | 11,121 | 796 | 3,630 | 1,812 |
| 20-Day Average Volume | 232,859 | 1,790,681 | 2,331,440 | 4,911,481 | 9,251,605 |
| Previous Close | 10.23 | 195.78 | 344.86 | 133.29 | 59.39 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 9.91 | 198.89 | 349.53 | 138.25 | 59.21 |
| 20-Day Raw Stochastic | 58.90% | 58.14% | 40.89% | 15.07% | 48.15% |
| 20-Day Relative Strength | 61.73 | 49.73 | 44.17 | 40.12 | 52.23 |
| Weighted Alpha | -30.00 | +39.61 | +21.36 | +25.90 | +28.82 |
| Today's Opinion | 56% Buy | 72% Buy | 24% Buy | 24% Buy | 64% Buy |
| Previous Opinion | 56% Buy | 64% Buy | 24% Buy | 24% Buy | 64% Buy |
| Last Month's Opinion | 8% Sell | 40% Buy | 56% Buy | 56% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.45% since 04/15/26 | -2.07% since 04/15/26 | -0.92% since 04/15/26 | -4.24% since 04/15/26 | +3.01% since 04/15/26 |
| Low | 10.23 on 04/21/26 | 195.77 on 04/21/26 | 340.06 on 04/21/26 | 132.22 on 04/21/26 | 57.66 on 04/16/26 |
| High | 11.25 on 04/16/26 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 140.26 on 04/16/26 | 60.48 on 04/17/26 |
| 1-Month | |||||
| %Chg | +18.85% since 03/20/26 | +7.32% since 03/20/26 | -0.80% since 03/20/26 | -2.46% since 03/20/26 | +3.74% since 03/20/26 |
| Low | 8.62 on 03/24/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 132.22 on 04/21/26 | 56.45 on 03/24/26 |
| High | 11.48 on 04/13/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | +36.47% since 01/22/26 | +7.45% since 01/22/26 | -0.59% since 01/22/26 | +2.06% since 01/22/26 | +8.54% since 01/22/26 |
| Low | 6.28 on 02/17/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 131.00 on 01/23/26 | 54.21 on 01/29/26 |
| High | 11.48 on 04/13/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -3.53% since 10/22/25 | +18.09% since 10/22/25 | +16.57% since 10/22/25 | +10.19% since 10/22/25 | +34.33% since 10/22/25 |
| Low | 6.28 on 02/17/26 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 11.48 on 04/13/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,469,136 | 303,636,768 | 186,115,760 | 165,442,480 | 121,258,640 |
| Shares Outstanding, K | 339,114 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 803,790,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -7,130,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | N/A | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | N/A | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | -0.86 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/21/26 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.91 | 16.03 | 16.67 | 9.61 |